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Spinal dorsal horn circuits receive, process, and
transmit somatosensory information. To understand
how specific components of these circuits contribute
to behavior, it is critical to be able to directlymodulate
their activity in unanesthetized in vivo conditions.
Here, we develop experimental tools that enable
optogenetic control of spinal circuitry in freelymoving
mice using commonly available materials. We use
these tools toexaminemechanosensoryprocessing in
the spinal cord and observe that optogenetic activa-
tion of somatostatin-positive interneurons facilitates
both mechanosensory and itch-related behavior,
while reversible chemogenetic inhibition of these neu-
rons suppresses mechanosensation. These results
extend recent findings regarding the processing of
mechanosensory information in the spinal cord and
indicate the potential for activity-induced release of
the somatostatin neuropeptide to affect processing
of itch. The spinal implant approach we describe
here is likely to enable a wide range of studies to
elucidate spinal circuits underlying pain, touch, itch,
and movement.
INTRODUCTION
A key virtue of the optogenetic approach to the control of neural
circuitry has been the ability to directly link neural activation to
behavior and, in so doing, test predictions of proposed circuit
models. While this approach has been very powerful in the brain
(Adamantidis et al., 2015; Boyden, 2015; Deisseroth, 2015) and
peripheral nervous system (Copits et al., 2016; Iyer et al., 2014;
Montgomery et al., 2016), the application of optogenetic controlCell Repo
This is an open access article under the CC BY-Nin the mammalian spinal cord has been largely restricted to
ex vivo slice preparations (Carr and Zachariou, 2014; Dougherty
et al., 2013; Foster et al., 2015; Ha¨gglund et al., 2010, 2013; Tal-
palar et al., 2011; Wang and Zylka, 2009; Yang et al., 2015;
Zhang et al., 2014), which do not allow for direct analysis of
the behavioral consequences of neural control.
Oneof themost influential circuitmodels in thespinal cord is the
‘‘gate control circuit,’’ proposed by Melzack and Wall in 1965
(MelzackandWall, 1965) toexplainempirical observations related
to acute and chronic pain perception, specifically, the emergence
of allodynia in chronic pain, and the dampening of pain sensation
by innocuous touch. In this model, light touch fibers preferentially
synapse not only on an inhibitory interneuron (a ‘‘gate’’ cell) in the
dorsal spinal cord but also on an excitatory projection neuron
(known as a ‘‘T’’ cell). Pain fibers synapse only on the T cell, which
also receives inhibitory drive from the gate cell. Thus in non-path-
ological conditions, light touch acts to dampen pain sensation,
through activation of the gate cell. This is in contrast to chronic
pain conditions, wherein the efficacy of gate cell inhibition is
reduced and thus the activation of light touch fibers induces,
instead of attenuates, pain. Fifty years after the proposal of this
circuit, neurons whose electrophysiological response properties
agree with major testable predictions of this model have been
identified. Specifically in mechanosensation, somatostatin-posi-
tive (SOM+) interneurons, glutamatergic neurons in layer 2/3 of
the superficial dorsal horn, have been proposed as the T cell in
the Melzack and Wall model (Duan et al., 2014). While behavioral
responses to ablation of these neurons (i.e., a reduction in me-
chanical sensitivity andmechanical allodynia) agreewithMelzack
and Wall’s predictions (Duan et al., 2014), researchers have
lacked the tools to test predictions associated with the activation
of these neurons in vivo.
Here, we developed a method to optogenetically activate dor-
sal horn neurons in awake, behaving rodents that was compat-
ible with typical pain assays and relied only on off-the-shelf
products. Using this system, we find that activation of SOM+rts 17, 1699–1710, November 1, 2016 ª 2016 The Author(s). 1699
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Implantation of Fiber Optic Ferrules for Light Delivery to the Spinal Cord
(A) Schematic showing relevant surgical landmarks.
(B–E) Schematics showing process of implantation of fiber optic cannula.
(F) Representative longitudinal spinal cord sections from control and implanted mice stained for astrocyte (GFAP) or microglia activations (Iba1). Two sections
each from n = 3 experimental and n = 3 control mice were analyzed. Scale bar, 1 mm.
(G) Close-up of implantation region for Iba1- and GFAP-stained longitudinal sections. Scale bar, 250 mm.
(H) Schematic showing CatWalk and representative gait trace of cannulated mouse.
(legend continued on next page)
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neurons results in strong nocifensive behavior in an array of
pain assays, in broad agreement with gate control model predic-
tions. We also report that this neural population plays a role in
regulating pruritoception, most likely through activity-dependent
release of the neuropeptide somatostatin. While these results
indicate that activation of SOM+ neurons is generally consistent
with predictions from the gate control model, they also sug-
gest that this population of neurons may play a broader role in
the regulation and processing of peripheral somatosensory sig-
nals, highlighting the complex and interwoven nature of spinal
circuitry.
RESULTS
Implantation Strategy and Characterization of In Vivo
Utility
We first developed a surgical implantation procedure to attach a
standard fiber optic ferrule (commonly used in the brain) to the
thoracic or lumbar spinal column (Figures 1A and S1; see Sup-
plemental Experimental Procedures). Two primary constraints
guided procedure development. First, the implant should be
secured to only a single vertebral segment to allow for freemove-
ment of the spinal column (Figures 1B and 1C). Second, the
implant should not penetrate the spinal parenchyma but instead
must remain superficial to the cord, due to the relativemotion be-
tween the cord and its vertebral housing (Figures 1D and 1E).
After cannula implantation, mice remained housed in a
group and displayed no visible signs of distress or pathology.
To assess this, we quantifiedmouse behavior in affective, motor,
and somatosensory tasks and observed no implantation related
deficits (Figures 1H–1K and S2). To verify cannula placement, we
performed in vivo anesthetized recordings from the spinal cord
segment in which we implanted our cannula (lumbar segment
4) and confirmed that dorsal horn neurons in that region had a
receptive field on the plantar surface of the ipsilateral hindpaw
(Figure S2).
As a proxy for implant-induced damage, we stained sections
from implanted mice for markers for microglia (Iba1) or astro-
cytes (GFAP) (Figures 1F and 1G) (Canales et al., 2015). We
compared these sections to those from control mice that had
received a sham surgery but did not have a cannula implanted,
and we observed no difference between sections from the two
sets of mice. We performed this characterization 14 days after
cannula implantation, the time point at which we generally began
our behavioral experiments. Of the over 150 cannulations we
have performed since developing the procedure, cannulae
have become dislodged prior to the sacrifice of the animal in
only 6 cases, comparable to the failure rates observed in stan-
dard brain cannula implantation procedures.
To verify that we could drive behavioral changes by optoge-
netically activating neurons in the spinal cord with light delivered
through our implanted cannula, we expressed ChR2 in a non-
specific population of spinal cord neurons through intraparen-(I) Stride length of ipsilateral versus contralateral paws of implanted mice (n = 5.
(J) Mechanical withdrawal thresholds of cannulated and uncannulatedmice, asme
withdrawal latencies of cannulated and uncannulated mice, as measured on the
All group data are shown as mean ± SEM.chymal injection of AAVDJ:CaMKIIa:ChR2-eYFP in the spinal
cord. The transduced population included dorsal and ventral
horn neurons, such that optical activation caused visible
hindlimb contraction and nocifensive behavior (Figure S2;
Movie S1). We histologically verified optical activation of neu-
rons through staining for c-Fos (Figure S2). In addition to veri-
fying that light delivered through implanted cannulae could drive
behavioral responses, these results also demonstrated potential
applications of this technique to studying ventral horn circuits
underlying spinal motor control. We performed a Monte Carlo
simulation of light propagation (Stujenske et al., 2015) to deter-
mine the expected depth of functional optogenetic excitation
(Figure S2). We observed that sufficiently high levels of light in-
tensity (>0.5 mW/mm2) could be achieved at depths up to
1 mm in the spinal cord with 10 mW of light output from the fiber.
Optogenetic Activation of SOM+ Interneurons
Having validated the utility of the spinal cord implant for in vivo
neuromodulation, we then turned to the gate control circuit
model. If SOM+ interneurons are homologous to T cells, the
model (Figure 2A) predicts that their activation would directly
engage ascending pain pathways. This would be reflected
behaviorally both through an immediate reflexive nocifensive
response and through behavioral manifestations of aversion rep-
resenting the affective dimension of pain (associated negative
emotional valence) (Duan et al., 2014; Melzack and Wall, 1965).
To test this prediction, we injected transgenic mice expressing
Cre in somatostatin neurons (SOM-Cre mice) with AAV:Ef1a:
DIO:ChR2-eYFP. The extent and distribution of ChR2-eYFP
expression was largely as previously described (Duan et al.,
2014), with an enrichment of cell bodies dorsal to, but not over-
lapping with, protein kinase C gamma (PKCg) neurons (which
denote the lamina II/III border (Malmberg et al., 1997) and a
dense network of axons and dendrites throughout the dorsal
horn (Figure 2B). Importantly, we saw no retrograde expression
of ChR2-eYFP in DRG neurons (Figure 2B).
We verified with slice electrophysiology that blue light illumina-
tionofSOM-ChR2neurons evoked light-inducedcurrent and sub-
sequent action potentials at intensities as low as 0.002 mW/mm2
(Figure S3). Light-evoked current increased with increasing light
powerdensity, asdid theprobability ofactionpotentialgeneration.
ChR2-expressing neurons faithfully followed light pulse trainswith
frequencies ranging from 1 to 10 Hz (10 ms pulse width). Consis-
tent with known properties of ChR2, probability of action potential
generation decreased at higher frequencies (Figure S2).
Next, we optogenetically stimulated SOM-ChR2 interneurons
in awake mice. Consistent with model predictions, mice showed
an immediate nocifensive response to blue light stimulation (Fig-
ure 2C; Movie S2). Mice consistently licked the appropriate
dermatomes and, with variation in lumbar implant site, engaged
in licking that ranged in location from the ipsilateral thigh to
the plantar surface of the ipsilateral hindpaw. We then assessed
whether a negative emotional valence was associated withp = 0.397).
asured on the von Frey test (n = 10 implanted, 10wild-type; p = 0.528). Thermal
Hargreaves test (n = 10 implanted, 10 wild-type. p = 0.47).
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Figure 2. Optogenetic and Chemogenetic Modulation of Somatostatin Interneurons
(A) Diagram of primary afferent to brain circuit containing somatostatin interneurons. Hypothesized and/or polysynaptic connection shown in dotted lines.
(B) Histology showing somatostatin expression (sections from n = 3 mice were examined for quantification). Scale bar, 250 mm; inset, 100 mm.
(C) Spontaneous response score of YFP mice compared to ChR2 mice in somatostatin interneurons (n = 5 ChR2, 5 YFP, p = 4 3 104).
(D) Latency to lick response of somatostatin mice versus threshold light power (n = 7 mice, each normalized to their individual threshold, binned in 5-s intervals,
and then averaged across mice).
(E) Thermal withdrawal latency during ‘‘subthreshold’’ blue light illumination of YFP mice and ChR2 mice (n = 5 ChR2, 5 YFP; p = 0.1 YFP, p = 0.21 control).
(F) Mechanical withdrawal thresholds of YFP and ChR2 mice at baseline and during subthreshold blue light illumination (n = 5 ChR2, 5 YFP; p = 0.421 YFP, p =
0.0173 ChR2).
(G) Conditioned place aversion (CPA) ratios, calculated as the ratio of the percentage of time spent in the stimulation chamber on the initial (pre-test) day and after
3 days of conditioning (n = 6 ChR2, 6 YFP; ChR2: p = 0.006, control: p = 0.208).
(legend continued on next page)
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activation of SOM+ neurons by testing whether optogenetic
activation was sufficient to generate conditioned place aversion
(Figure 2G). We found SOM-ChR2 mice spent significantly less
time in the chamber in which light was delivered after a training
period, while control mice expressing YFP did not show any
preference.
We then determined the light level that would elicit a behav-
ioral response from each mouse. This level ranged from 40 mW
to 3 mW and was less than 0.5 mW in four out of six tested
mice. Higher intensity thresholds are likely due to obstruction
of the cannula-spinal cord interface (Figures 2D and S2M).
We used each mouse’s individual ‘‘threshold’’ to determine light
levels for future behavioral experiments. We tested whether blue
light stimulation below this threshold would change the response
of the mice to mechanical and thermal stimuli. If SOM+ neurons
form the output of a purely mechanosensory gait circuit, then
sub-threshold activation of these neurons would decrease me-
chanical, but not thermal, thresholds. Consistent with these
predictions, we found that sub-threshold activation of somato-
statin interneurons significantly reduced mechanical thresholds
on the von Frey test but did not alter thermal thresholds on the
Hargreaves test (Figures 2E and 2F).
Transient Inhibition of SOM+ Interneurons
Previous studies examining SOM+ interneurons have used
genetic ablation strategies to characterize the function of these
neurons. However, recent reports indicate that the results of
transient neural silencing may differ dramatically from the results
of permanent ablation (Otchy et al., 2015). We therefore tested
whether transient inhibition of SOM+ interneuron activity would
confirm model predictions, recapitulating aspects of previously
observed behavior (Duan et al., 2014). Two major strategies
have been used to reversibly inhibit neural circuits: optogenetic
inhibition (Adamantidis et al., 2015; Boyden, 2015; Deisseroth,
2015) and the use of chemogenetic Gi-coupled designer
receptors exclusively activated by designer drugs (DREADDs)
(Armbruster et al., 2007; English and Roth, 2015; Iyer et al.,
2016; Urban and Roth, 2015). Here, we adopted a chemogenetic
strategy for two reasons: (1) lamina II neurons exhibit large ros-
tro-caudal patterns of activation in response to primary afferent
input (Nishida et al., 2014), and we were concerned that the
narrow field of illumination provided by an implanted fiber-optic
ferrule would not be sufficient to drive behavior; and (2) optoge-
netic inhibition typically requires high-intensity constant light,
which, given the high density of TRPV1 expression in nociceptor
terminals in the dorsal spinal cord, poses a significant heating-
related activation confound.(H) Histology indicating robust expression of hM4D in the spinal cord dorsal horn
that is non-overlapping with PKCg. Top row: transverse spinal cord section (red,
root ganglion section (red, hM4D-mCherry; cyan, DAPI ). Scale bar, 250 mm.
(I) Mechanical withdrawal thresholds following injection of CNO or saline in SOM-h
saline) = 0.52).
(J) Thermal withdrawal latency following injection of CNO or saline in SOM-hM4
saline) = 0.66).
(K) Cotton swab sensitivity following injection of CNO or saline in SOM-hM4D+ m
saline; post-CFA: n = 8 post-CNO, n = 8 post-saline; pre-CFA: p [post-CNO] = 1, p
group data are shown as mean ± SEM.We injected SOM-Cre mice intraspinally with AAV5:hSyn:
DIO:hM4D(Gi)-mCherry and assessed nociceptionwithmechan-
ical and thermal assays. hM4D(Gi)-mCherry expression was
consistent with previous results (Figures 2H and S4A). If SOM+
neurons are the T cells in the gate controlmodel, then they should
relay input fromAd andC-HTMR (high-thresholdmechanorecep-
tors) primary afferents to ascending pain pathways. Therefore,
chemogenetic inhibition of these neurons would be predicted
to transiently increase mechanical withdrawal thresholds. Gate
control also predicts that in naive animals, input from light-touch
afferents (Ab-, Ad- andC-LTMRs) should not be sufficient to drive
activation of T cells, and therefore, chemogenetic inhibition of
SOM+ cells should not have any effect on light touch. However,
inmice exhibitingmechanical allodynia, input from light-touch af-
ferents is relayed throughTcells, and therefore, chemogenetic in-
hibition of SOM+ cells should meaningfully reduce mechanical
hypersensitivity. Our behavioral results were consistent with
these predictions. In naive SOM-hM4Di mice, we observed that
following intraperitoneal injections of clozapine-N-oxide (CNO),
but not saline, mice showed a significant increase in mechanical
withdrawal thresholds, as well as a slight increase in heat with-
drawal latency, but no reduction in sensitivity to ameasure of light
touch (cotton swab assay; Figures 2I–2K). To examine the effects
of chemogenetic inhibition on mechanical allodynia, we injected
the paws of the animalswith complete Freund’s adjuvant (CFA), a
pro-inflammatory agent. As expected, CFA injection caused dy-
namic mechanical allodynia (Figure 2K). Consistent with model
predictions, intraperitoneal injection of CNO now significantly
reduced allodynia, restoring light-touch sensitivity to baseline
pre-CFA levels (Figure 2K). In addition, mice expressing hM4Di
displayed no differences in measures of locomotion following
CNO administration, as compared with following saline injection,
suggesting these results are not due to motor-related confounds
(Figure S4B).
Temporally Sparse Optogenetic Stimulation of SOM+
Interneurons Increases Histamine-Induced Itch
In recent work, it has been demonstrated that intrathecal admin-
istration of the somatostatin analog octreotide results in strong
scratching behavior that can be eliminated by ablation of Bhlhb5
neurons, which are a subpopulation of neurons that express
the 2A isoform of the somatostatin receptor (SST2AR) (Kardon
et al., 2014). When we immunostained spinal cord sections
from mice expressing ChR2 in SOM+ neurons for SST2AR, we
noticed significant spatial overlap between regions of strong
ChR2-eYFP expression and regions of strong SST2AR expres-
sion (Figure 3A). Thus, we were curious if, in addition to theirfollowing intraspinal injection of AAV5::hM4D, indicating expressing in lamina II
hM4D-mCherry; cyan, PKCg, overlap). Scale bar, 100 mm. Bottom row: dorsal
M4D+mice (n = 8 post-CNO, n = 8 post-saline; p (post-CNO) = 0.013, p (post-
D+ mice (n = 7 post-CNO, n = 7 post-saline; p (post-CNO) = 0.047, p (post-
ice before and after intraplantar CFA (pre-CFA: n = 8 post-CNO, n = 8 post-
[post-saline] = 0.84; post-CFA: p [post-CNO] = 0.015, p [post-saline] = 0.60). All
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Figure 3. Temporally Sparse Optogenetic Stimulation of Somatostatin Interneurons Modulates Pruritoception
(A) Histology indicating significant spatial proximity between ChR2+ neurons and SST2R immunoreactivity in SOM-ChR2+mice. Clockwise from top-left: green,
ChR2-eYFP; blue, DAPI; red, SST2R immunoreactivity; overlay. Scale bar, 100 mm.
(B) Time spent itching during sparse optogenetic stimulation in SOM-ChR2 and SOM-mCherrymice, with concurrent intrathecal CYN-154806 or intrathecal saline
(n = 6 SOM-ChR2+ mice, n = 5 SOM-mCherry+ mice; p [SOM-ChR2] = 0.028, p [SOM-mCherry] = 0.47).
(C) Thermal withdrawal latency during sparse optogenetic stimulation in SOM-ChR2 and SOM-mCherry mice, with concurrent intrathecal CYN-154806 or
intrathecal saline (n = 5 mice in all conditions, p [SOM-ChR2 + CYN-154806] = 0.042, p [SOM-ChR2 + saline] = 0.77, p [SOM-mCherry + CYN-154806] = 0.54,
p [SOM-mCherry + saline] = 0.78).
(D) Mechanical withdrawal thresholds during sparse optogenetic stimulation in SOM-ChR2 and SOM-mCherry mice, with concurrent intrathecal CYN-154806 or
intrathecal saline (n = 5 mice in all conditions, p [SOM-ChR2 + CYN-154806] = 0.37, p [SOM-ChR2 + saline] = 0.10, p [SOM-mCherry + CYN-154806] = 0.22,
p [SOM-mCherry + saline] = 0.25. All group data are shown as mean ± SEM.role in gate control, SOM+ neurons may contribute to regulation
of itch through activity-dependent release of somatostatin. We
designed an experiment to test this hypothesis. We injected his-
tamine intradermally into the thigh of SOM+ mice expressing
either ChR2 or mCherry and concurrently performed intrathecal
(IT) injections of either saline or the SST2R antagonist CYN-
154806. We then optogenetically stimulated these mice with a
temporally sparse 1-Hz, 100-ms pulse train, titrating light in-
tensity on a mouse-by-mouse basis to minimize stimulation
evoked paw-licking behavior, and we then video recorded
histamine-evoked thigh-biting behavior. We observed that in
SOM-ChR2 mice, but not in SOM-mCherry controls, optoge-
netic stimulation paired with IT saline resulted in high rates of1704 Cell Reports 17, 1699–1710, November 1, 2016histamine-evoked thigh biting, as compared to optogenetic
stimulation paired with IT CYN-154806 (Figure 3B). In contrast,
when temporally sparse optogenetic stimulation and IT saline/
CYN-154806were pairedwithmeasures ofmechanical and ther-
mal sensitivity, no significant differences were observed upon
optogenetic stimulation in either IT saline or IT CYN-154806
conditions (Figures 3C and 3D).
SOM+ Neuron Activation Recruits Ascending Pain
Pathways
A critical prediction of gate theory is that activation of T cells re-
sults in recruitment of ascending pain pathways. Although previ-
ous work (Duan et al., 2014) suggested that SOM+ interneurons
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Figure 4. c-Fos Activation in the Dorsal Horn after Stimulation of Somatostatin Interneurons
(A) ChR2-eYFP fluorescence in the dorsal horn after intraspinal injection of AAVDJ:ef1a:DIO:ChR2-eYFP in SOM-IRES-Cre mice.
(B) Immunostaining for NK1R in the dorsal horn of the spinal cord.
(C) c-Fos expression in the dorsal horn after expression of somatostatin in the spinal cord.
(D) Merge of c-Fos, ChR2-eYFP, and NK1R channels. Scale bar, 250 mm (A–D).
(E) Examples of overlap of c-Fos and YFP (closed arrows), or c-Fos and NK1R (open arrows). Scale bar, 250 mm.
(F) Quantification of overlap of c-Fos, YFP, and NK1R expression. Note: 56% ± 8% of ChR2+ cells are also c-Fos+, the ChR2+/c-Fos+ to ChR2/c-Fos+ ratio is
2.55 ± 0.44.
(G) Visualization of overlap.
(H) Quantification of depth of c-Fos-expressing neurons in the dorsal horn. Lamina depths are denoted with dotted lines and roman numerals.relay mechanosensory information to neurons in laminae I and
II, the genetic identity of these neurons, and whether they project
to supraspinal centers, was unknown. We assayed downstream
activity induced by optogenetic activation of SOM+ neurons
through c-Fos immunohistochemistry. We found c-Fos+ neu-
rons in both superficial laminae and deep dorsal horn laminae,
including neurons that express NK1R, a subset of which are
known to relay pain information to supraspinal centers (Todd,
2002; Figures 4A–4H).DISCUSSION
In the past decade, researchers have begun to employ increas-
ingly sophisticated in vivo genetic tools to piece together sub-
sets of spinal cord sensory circuits responsible for processing
external stimuli. These tools have enabled the investigation of
behavioral responses to ablation of subsets of dorsal horn neu-
rons either during development (Duan et al., 2014) or in adult-
hood (Foster et al., 2015). However, these approaches are notCell Reports 17, 1699–1710, November 1, 2016 1705
without limitations. Genetic knockout strategies can introduce
interpretational confounds due to the absence of knocked out
genes during development, while cellular ablation is permanent
and may differ in its effects from transient silencing (both due
to the potentially toxic byproducts of cellular ablation and
recently characterized differences between the effects of tran-
sient and chronic neural silencing; Otchy et al., 2015).
Here, we have described how standard optogenetic tools can
be co-opted for use in the spinal cord, enabling direct selective
control of spinal circuits in freely moving mice. The implantation
strategy we describe does not impede locomotion, alter baseline
responses to measures of somatosensory sensitivity, or induce
significant anxiety. The optogenetic tools we use in this work
are currently available for $20 per implant and require no
additional fabrication or construction after purchase. They there-
fore may enable a substantial cost and time savings for the large
fraction of experiments in which wirelessly powered implants
(Ho et al., 2015; Montgomery et al., 2015; Park et al., 2015) are
unnecessary. A recent publication by Bonin et al. describes
an alternative tethered approach to light delivery to the spinal
cord in which the fiber-optic cable is attached to the skull and
tunneled epidurally until it rests dorsal to the cord (Bonin et al.,
2016). This approach is valuable in experiments where stimula-
tion and injection of a large rostro-caudal section of the spinal
cord is useful; however, as the emitted light from such implants
spreads spherically, only a quarter of the emitted light is directly
ventrally into the cord, reducing the maximum light intensity that
can be achieved using this approach.
In addition to controlling sensory dorsal horn circuits, the
optogenetic implantation procedure described here could be
applied to dissect a variety of physiological processes controlled
by spinal circuitry. These include locomotion and respiration-
related motor circuits, which have been studied extensively in
ex vivo (Dougherty et al., 2013; Ha¨gglund et al., 2010, 2013)
and anesthetized preparations (Alilain et al., 2008; Wang et al.,
2013) but have not been manipulated in freely moving unanes-
thetized animals.
These results form part of a growing body of knowledge
regarding the molecular identity and functional role of the neu-
rons that comprise the gate control circuit in the spinal dorsal
horn (Bourane et al., 2015; Duan et al., 2014; Petitjean et al.,
2015). In particular, the rapid and strong nature of the behavioral
response to SOM-ChR2 stimulation was striking. Mice engaged
in highly consistent patterns of examining and licking the derma-
tomally appropriate region but did not typically shake their paw
or flinch (as we have previously observed in response to optoge-
netic activation of ummyelinated primary afferent nociceptors or
as is observed in the von Frey or Hargreaves test). This response
highlights the strong salience of SOM+ neuron activation and is
consistent with the pattern of activity-induced c-Fos and predic-
tions from the gate control model.
Our results demonstrating the consequences of transiently
chemogenetically suppressing SOM+ interneurons broadly
agree with previous ablation studies (Duan et al., 2014). This is
particularly interesting given that the neuronal population we
controlled (both during optogenetic activation and during
chemogenetic inhibition) is restricted to neurons that express
somatostatin in adulthood. Unlike previous reports that used a1706 Cell Reports 17, 1699–1710, November 1, 2016developmental genetic intersectional strategy (Duan et al.,
2014), we do not observe overlap of transgene expression with
the PKCg neuronal population, indicating that inhibition of the
SOM+ PKCg population is sufficient to drive gate control
theory-predicted inhibition of mechanical allodynia.
Our results here synthesize two lines of evidence regarding
processing of mechanosensation and pruritoception in the
spinal cord (Duan et al., 2014; Kardon et al., 2014). Optogenetic
activation of SOM+ interneurons results in an increase in hista-
mine-evoked itch behavior that may be mediated through the
somatostatin neuropeptide and therefore through suppression
of SST2AR-expressing neurons, indicating a broader role for
these neurons in the regulation of somatosensory stimuli beyond
their excitatory role in gating mechanosensory inputs. It remains
to be seen whether endogenous activity in SOM+ neurons can
result in somatostatin release and, if so, how such release inter-
acts with the inhibition of itch by counter-stimuli (Snyder and
Ross, 2015). In addition to a somatostatin-mediated effect on
itch, it is important to note that our experiments do not rule out
a potential additional glutamatergic effect. Future experiments
will be required to more completely assess the relative contri-
bution of these two pathways to itch perception. However, the
attenuation of optogenetically evoked itch facilitation by intra-
thecal administration of SST2R antagonists indicates that so-
matostatin plays a significant role in this process. These results
are indicative of the broader palette of experiments now possible
due to easy optogenetic access to the spinal dorsal horn.
EXPERIMENTAL PROCEDURES
Animal Test Subjects and Experiments
Animal procedures were approved by the Stanford University Administrative
Panel on Laboratory Animal Care. Mice were either female C57BL/6 mice or
Ssttm2.1(cre)Zjh/J mice (Jax 013044) housed under a 12-hr/12-hr light/dark
cycle, with food and water available ad libitum. Mice were randomly assigned
by cage to control and experimental groups, and controls and experimental
groups were age matched. For all experiments, mice were 6–10 weeks old
at the time of injection or implantation and received cannula implanta-
tion 2 weeks prior to beginning of experiments. Control mice for optoge-
netic somatostatin experiments were C57BL/6 mice (the genetic background
of the SOM transgenic mice) and received spinal cord injections of AAVDJ:
CaMKIIa:eYFP.
General Statistical Methods
Data that were known to be drawn from a non-normal distribution (von Frey
measures of mechanical withdrawal) were analyzed using non-parametric
statistical tests such as theMann-WhitneyU test. In some cases (spontaneous
response score), the data were transformed such that it was normal, and then
a two-way ANOVAwas used to detect significance. All data were analyzed us-
ing paired tests; generally, the two-tailed Student’s t test was used, except for
comparing group percentage changes in conditioned place aversion. In that
case, as the populations had similar variance, a homoscedastic test, such
as Levene’s test, was used. Finally, sample sizes were estimated using a =
0.05 and power (1  b) = 0.8. Based on prior pilot experiments, effect sizes
of 0.5–0.8 resulted in sample sizes of approximately five to ten mice for the
behavioral experiments.
Inclusion and Exclusion Criteria
Exclusion conditions were determined prior to the beginning of experi-
ments. For all experiments, prior to blinding, mice were tested for sensi-
tivity to light. Mice who did not display a response upon illumination were
excluded from study. Under this condition, one mouse was excluded from
the AAVDJ:CaMKIIa:ChR2-eYFP experiments. All SOM-ChR2 mice were light
sensitive on initial testing. Mice were also excluded if their cannulae became
dislodged during experiments. One SOM-ChR2 mice was excluded under
this criterion. For conditioned place preference (CPP) tests, if on initial testing
mice showed a preference for a specific side of the chamber that was greater
than 65% or less than 35%, they were excluded. One SOM-ChR2 mouse was
excluded under this criterion.
Spinal Cord Injection and Implantation of Fiber Optic Cannulae
Virus Preparation
For initial behavioral characterization experiments, 6- to 8-week-old C57BL/6
female mice (Charles River Laboratories) were injected with 2 mL AAVDJ:CaM-
KIIa:ChR2-eYFP (2 3 1012 vg/mL) or 2 mL AAVDJ:CaMKIIa:eYFP (3.4 3 102
viral genome-containing particles (vg)/mL). For somatostatin experiments,
6- to 8-week-old SOM-Cre mice were injected with 1–2 mL AAVDJ:ef1a:
DIO:ChR2-eYFP (2 3 1012 vg/mL), or 6- to 8-week-old C57BL/6 mice were
injected with 1–2 mL AAVDJ:CaMKIIa:eYFP (3.43 1012 vg/mL). For chemoge-
netic experiments, 6- to 8-week-old SOM-Cre mice were injected with 1 mL
AAVDJ:ef1a:DIO:HM4D(Gi)-mCherry or AAV5:ef1a:DIO-mCherry.
Injection and Implantation
Spinal cord injections and implantations are described in detail in the supple-
mentary protocol. Briefly, mice were anesthetized under 2%–3% isoflurane.
Once a stable plane of anesthesia was reached, the area surrounding the
dorsal hump was shaved and then cleansed with alternating applications of
Betadine and alcohol. A 1- to 2-cm incision was made slightly caudal to the
peak of the dorsal hump in order to expose the lumbar spinal region. The
vertebra of interest was identified, and then a small incision was made be-
tween the tendons and the vertebral column on either side. The vertebra
was then secured using spinal adaptor clamps, and all the tissue was removed
from the surface of the bone. Using a microdrill, we removed the spinous pro-
cess and roughed the surface of the vertebra. Next, a small hole was drilled
2 mm from midline, centrally on the rostral-caudal axis. If injections were
necessary, they were made through this hole at a depth of 200 mm from
the surface of the spinal cord using standard stereotaxic injection procedures.
1–2 mL virus was injected at a rate of 0.15 mL/min. We waited 5–10 min before
removing the needle.
If a cannula was to be implanted, we first cleaved the end of the fiber optic to
a length less than 1 mm and then positioned it above the drilled hole. We used
a small amount of superglue around the drill hole and over the surface of the
bone to reduce the possibility of bone bleeds and secure the cannula in place.
Next, we cemented the cannula in place using dental cement and, after the
cement dried, sutured the skin surrounding the dental cement. We gave car-
profen and buprenorphine subcutaneously and lidocaine locally. Mice were
allowed to recover under a heat lamp before being returned to their cage.
Mice continued to be group housed after this procedure was performed.
Conditioned Place Aversion
Conditioned place aversion experiments were performed largely as previously
described (Cunningham et al., 2006). On the first day of testing, mice were first
contained to the central room for 1 min and then allowed to freely roam the
apparatus for 30min. On the second through fourth days, micewere contained
to the non-stimulation side of the chamber for 10 min in the morning, and then
at least 4 hr later, they were contained to the opposite side of the chamber for
another 10 min, where they received optogenetic stimulation. Control and
experimental mice were randomly assigned to sides of the chamber, such
that the number receiving stimulation in each side was balanced. For somato-
statin mice, stimulation parameters were 10 Hz blue light at a 20% duty cycle
(DC) at a stimulation intensity 130%–150% of the previously determined
threshold value. Control mice were randomly assigned stimulation intensity
such that each control mouse had the same stimulus parameters as one of
the experimental mice. Because the same number of control and experimental
mice were tested, the stimulation parameters were exactly matched between
groups.
Electrophysiology
In vivo electrophysiology was performed largely as previously described (Yiz-
har et al., 2011). In brief, a laminectomy was performed on the L4 vertebrasegment, and an optrode was lowered as superficially into the spinal cord
as possible. Units were located by listening to their firing while the optrode
was advanced or retracted until the point at whichmaximum amplitude of firing
was obtained. To screen for receptive fields, forceps were lightly tapped
against the skin until an area that the unit responded to was found. Units for
which a receptive field could not be foundwere not included in this study. Units
were classified based on whether their receptive field was on the plantar
surface of the right hindpaw or not, and the xyz coordinates of the unit were
recorded using a digital stereotaxic display. Zero was considered the intersec-
tion of the L3 and L4 spinal vertebral segments at midline.
Spinal Cord Slice Preparation and Electrophysiology
Spinal cord slice preparation and electrophysiology were performed as has
been previously described (Bardoni et al., 2014). Briefly, 2 weeks after virus in-
jections, mice were anesthetized with isoflurane abd decapitated, and the
vertebral column was rapidly removed and placed in oxygenated ice-cold
dissection solution (95 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 26 mM
NaHCO3, 50 mM sucrose, 25 mM glucose, 6 mM MgCl2, 1.5 mM CaCl2, and
1mMkynurenic acid [pH 7.4], 320mOsm). The lumbar spinal cordwas isolated
and embedded in a 3% agarose block, and transverse slices (400 mm thick)
were made using a vibrating microtome (Leica VT1200). Slices were incubated
in oxygenated recovery solution (125 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 26 mM NaHCO3, 25 mM glucose, 6 mM MgCl2, and 1.5 mM
CaCl2 [pH 7.4], 320 mOsm) at 35
C for 1 hr. Patch-clamp recording in
whole-cell configuration was performed at room temperature on lamina II
neurons visualized with an Olympus BX51WI with Nomarski optics and con-
nected to a camera (Q-imaging). Recordings were performed in current-clamp
mode or voltage-clamp mode at a holding potential of 70 mV. Thick-walled
borosilicate pipettes, having a resistance of 3–5 MOhm, were filled with inter-
nal solution (120 mM K-methyl-sulfonate, 10 mM NaCl, 10 mM EGTA, 1 mM
CaCl2, 10 mM HEPES, 0.5 mM NaGTP, and 5 mM MgATP, with pH adjusted
to 7.2 with KOH and osmolarity adjusted to 305 with sucrose). Light stimula-
tions were evoked via Lambda Tled controller at a wavelength of 530 nm
(Sutter). Data were acquired using a Multiclamp 700A amplifier and pClamp9
software (Molecular Devices). The sampling rate was 10 kHz, and data were
filtered at 2 kHz.
Measurement of Threshold Light Intensity
To measure the threshold light intensity at which somatostatin mice began re-
sponding to stimulation, mice were placed in individual tubes with cannulae
attached and allowed to first habituate for 30 min. Following habituation,
each mouse was sequentially screened for approximate current driving a
Thorlabs LED driver at which they flinched. Once an approximate current
was established, testing began 30–40 mA below that threshold. A stopwatch
was used to measure the latency until mice attended the stimulus (which
was a lick response in all cases). A cutoff value of 20 s was chosen (i.e., stim-
ulus did not continue more than 20 s). At 5-min intervals, LED intensity was
increased by 10 mA. Once the time to attendance dropped below 1 s, tests
were halted. The current value at which themouse response time first dropped
below 20 s was chosen as the threshold value and was used in future exper-
iments with that specific mouse. These current values were then normalized
to threshold and plotted against threshold plus or minus a delta (10 mA steps).
Measurement of Mechanical Withdrawal Thresholds
Mice were habituated to the testing apparatus for 30 min prior to testing.
Von Frey hairs of different forces were applied to the plantar surface of the
paw using a previously described up-down method (Chaplan et al., 1994).
The following counted as withdrawal responses: rapid flinch or withdrawal,
paw flutter, spreading of the toes, or licking of the paw.
For measurements comparing cannulated mice with wild-type mice, an
opaque sheet of construction paper was wrapped around the containment
tube, such that only the paws of the mice were visible to the experimenter.
This allowed experimenters to be blinded to the condition of the mice.
For measurements of mechanical withdrawal threshold during subthreshold
blue-light illumination, mice were assigned an individual light power based
on previous experiments. A value of 80% of threshold was assigned to each
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was always 10 Hz at 20% duty cycle. During the test, a second unblinded
experimenter adjusted the threshold from mouse to mouse, without revealing
the light power to the experimenter performing the test. Different light output
powers were not visually distinguishable.
Measurement of Thermal Withdrawal Latency
We measured thermal sensitivity using a Hargreaves apparatus (Ugo Basile).
For experiments comparing wild-type mice with cannulated mice, the contain-
ment tubes were wrappedwith construction paper as in the von Frey test. Sub-
threshold blue-light experiments were performed using the same experimental
paradigm as used in the von Frey test.
Chemogenetic Experiments
Compound Administration
In all chemogenetic experiments, the ligand used was clozapine-N-oxide
(CNO; C0832, Sigma-Aldrich). CNO was diluted to a concentration of
2 mg/mL in PBS and administered to the animal in a 100-mL dose for a dose
of 200 mg (10 mg/kg). Animals that received a control injection received
100 mL PBS. In both cases, mice were briefly anesthetized (<30 s under
2.5% isoflurane), and injections were intraperitoneal. Injections were always
performed 1 hr prior to behavioral testing. Mice were assigned to CNO or con-
trol groups randomly and all behavioral testing was performed in a blinded
fashion.
Open-Field Analysis
To control for the potential for CNO-induced effects on locomotion, mice were
assayed post-injection in an open-field environment. Mice were randomly as-
signed to first receive an injection of saline or CNO (10 mg/kg) following injec-
tion practices identical to those previously described. 1 hr post-injection, mice
were placed in a 31-cm 3 26.5-cm rectangular environment, and their motion
was videotaped for 5 min. 6 hr later, mice received a second intra-peritoneal
injection different from the injection they received in the first round and were
then placed once more in the rectangular environment. Animal motion was
analyzed using BIOBSERVE Viewer 2. Measures assessed include the time
spent in the center of the rectangular zone (19 cm3 14.5 cm), and the average
velocity of animal movement over the 5-min period.
Measurement of Histamine-Induced Itch with Concurrent
Optogenetic Stimulation and Intrathecal Agent Administration
Mice used in this experiment were SOM-ChR2+ or mCherry+ mice. Mice were
initially briefly anesthetized (<1 min at 2.5% isoflurane) and received both an
intradermal injection of histamine dichloride (20 mL, 400 mg) as well as an intra-
thecal injection of either PBS or the SST2R antagonist CYN-154806 (10 mL in-
jection, 250 ng). Intrathecal injections were performed using a 30G syringe.
Needle insertion was confirmed with a visible tail flick.
Measurement of Sensorimotor Coordination
Measurement of adhesion tape removal latency was not performed in a blind
manner, as it was impossible to apply the sticky tape without observing
whether or not a mouse was cannulated. Mice were briefly restrained and a
piece of sticky tape was applied to the dorsal surface of the right hindpaw.
The amount of time until themouse began trying to remove the tape was deter-
mined using a stopwatch.
Spontaneous Response Scoring
To judge whether a mouse responded to spinal cord illumination in a blinded
fashion, we developed a scoring method whereby mice were assigned a
score of zero, one, or two based on an observer’s certainty that the mouse re-
sponded to the onset of illumination. A score of two corresponded to absolute
certainty of a behavioral response, and a score of zero corresponded to no
behavioral response. A score of one was given to mice that seemed to attend
the stimulus but did not display a clear, canonical response.
Gait Analysis
The CatWalk analysis and the required training protocol has been described
elsewhere (Deumens et al., 2007; Hamers et al., 2001). For our studies, mice
were trained and tested on the same day. The mouse home cage was placed
at the end of the walkway as a reward, and animals were trained with at least1708 Cell Reports 17, 1699–1710, November 1, 2016three runs across the walkway before testing. Trials were included if the
following parameters were met: minimum run duration: 0.5 s, maximum run
duration: 15 s, minimum number of compliant runs to acquire: three, maximum
allowed speed variation: 60%. We averaged across three compliant trials for
each mouse.
To analyze these data, contralateral paws were used as internal controls; as
all implantationswerebilateral, anydamagewouldpresent itself as agait asym-
metry. We analyzed stride length, swing time, swing speed, and stance time.
Computational Modeling of Light Propagation
We adopted a simulation approach developed by Joshua Gordon (Stujenske
et al., 2015), modifying the MATLAB scripts available in that work. Briefly,
the simulation performs a Monte Carlo simulation of photons doing a random
walk through tissue after realistically modeled emission from a fiber-optic
cannulae. Due to the prevalence of white matter tracts in the spinal cord, we
modified the stimulation parameters used by Stujenske et al. (absorption, scat-
tering, and anisotropy constants) to be those measured from ex vivo human
white matter (Yaroslavsky et al., 2002). This is an upper bound on the amount
of scattering expected in real spinal cord tissue, and therefore, our estimate of
light penetration depth is a conservative one.
Immunohistochemistry, Imaging, and Quantification of
Transduction
Mice were deeply anesthetized and then transcardially perfused with 10 mL
of 13 PBS and 10mL of 4%PFA. Spinal cords were dissected, fixed overnight
in 4% PFA, and then cryopreserved in 30% sucrose. After being frozen in
Tissue-Tek O.C.T, spinal cord sections were cut, either transversely or longi-
tudinally, at 20–40 mm on a cryostat (Leica CM3050S) and mounted on slides.
After rinsing, slides were blocked in 0.3% Triton X-100, 2% normal donkey
serum (NDS) in PBS for 1 hr. Samples were incubated at room temperature
overnight with primary antibodies (0.3% Triton X-100, 5%NDS, in PBS). Slides
were then rinsed in PBS, and then incubated at room temperature for 2 hr with
secondary antibodies in PBS. Slides were then rinsed and coverslipped using
PVA DABCO. Primary antibodies used were rabbit anti-GFAP (1:1000, #7260,
Abcam), rabbit anti-Iba1 (1:400, #019-19741, Wako Pure Chemicals Indus-
tries), rabbit anti-PKCg (1:400, #sc-211, Santa Cruz Biotechnology), guinea
pig anti-NK1R (1:500, AB15810, EMD Millipore), rabbit anti-SST2R (1:500,
ab134152, Abcam), and rabbit anti-cFos (1:500, ab7963, Abcam). Secondary
antibodies used were donkey anti-rabbit Cy5 (1:500, #711-175-152, Jackson
ImmunoResearch Laboratories), donkey anti-rabbit Cy3 (1:500, #711-165-
152, Jackson ImmunoResearch Laboratories), and donkey anti-guinea pig
Cy5 (1:500, #706-175-148, Jackson ImmunoResearch Laboratories).
Slides were imaged using a Leica TCS SP5 confocal scanning laser micro-
scopewith 103, 203, 403, and 633 objectives. Images were processed using
Fiji, and image brightness and contrast were adjusted if necessary. All such ad-
justments were applied uniformly to the entire image. For spinal cord PKCg
overlap experiments, one to three sectionspermousewere analyzed from three
mice expressing ChR2-eYFP and three mice expressing hM4D-mCherry.
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